Concomitant Infection of S. mansoni and H. pylori Promotes Promiscuity of Antigen-Experienced Cells and Primes the Liver for a Lower Fibrotic Response.


Journal

Cell reports
ISSN: 2211-1247
Titre abrégé: Cell Rep
Pays: United States
ID NLM: 101573691

Informations de publication

Date de publication:
02 07 2019
Historique:
received: 02 08 2018
revised: 29 01 2019
accepted: 29 05 2019
entrez: 4 7 2019
pubmed: 4 7 2019
medline: 28 8 2020
Statut: ppublish

Résumé

Helicobacter pylori chronically colonizes the stomach and is strongly associated with gastric cancer. Its concomitant occurrence with helminths such as schistosomes has been linked to reduced cancer incidence, presumably due to suppression of H. pylori-associated pro-inflammatory responses. However, experimental evidence in support of such a causal link or the mutual interaction of both pathogens is lacking. We investigated the effects of co-infection during the different immune phases of S. mansoni infection. Surprisingly, co-infected mice had increased H. pylori gastric colonization during the interferon gamma (IFNγ) phase of schistosome infection but reduced infiltration of T cells in the stomach due to misdirection of antigen-experienced CXCR3

Identifiants

pubmed: 31269443
pii: S2211-1247(19)30755-7
doi: 10.1016/j.celrep.2019.05.108
pii:
doi:

Substances chimiques

Antigens 0
Cytokines 0
Interferon-gamma 82115-62-6

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

231-244.e5

Informations de copyright

Copyright © 2019 The Authors. Published by Elsevier Inc. All rights reserved.

Auteurs

Sonakshi Bhattacharjee (S)

Institute for Medical Microbiology, Immunology and Hygiene, Technical University of Munich, Munich, Germany; German Centre for Infection Research (DZIF), partner site Munich, Munich, Germany.

Raquel Mejías-Luque (R)

Institute for Medical Microbiology, Immunology and Hygiene, Technical University of Munich, Munich, Germany; German Centre for Infection Research (DZIF), partner site Munich, Munich, Germany.

Eva Loffredo-Verde (E)

Institute for Virology, Technical University of Munich, Munich, Germany.

Albulena Toska (A)

Institute for Medical Microbiology, Immunology and Hygiene, Technical University of Munich, Munich, Germany.

Michael Flossdorf (M)

Institute for Medical Microbiology, Immunology and Hygiene, Technical University of Munich, Munich, Germany.

Markus Gerhard (M)

Institute for Medical Microbiology, Immunology and Hygiene, Technical University of Munich, Munich, Germany; German Centre for Infection Research (DZIF), partner site Munich, Munich, Germany. Electronic address: markus.gerhard@tum.de.

Clarissa Prazeres da Costa (C)

Institute for Medical Microbiology, Immunology and Hygiene, Technical University of Munich, Munich, Germany. Electronic address: clarissa.dacosta@tum.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH